Effects of acetate or bicarbonate dialysis solutions on serum HDL and HDL subfractions of patients undergoing haemodialysis

Current Medical Research and Opinion

Volumn 15, Issue 4, 1999, Pages 310-315

  Yalçin, Ayfer ^a   Kocaoǧlu, Şükran ^a   Akçiçek, Fehmi ^a   Özyer, Abdullah ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acetate dialysis; Bicarbonate dialysis; Haemodialysis; HDL cholesterol; HDL2 cholesterol; HDL3 cholesterol

Indexed keywords

ACETIC ACID; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BICARBONATE; CHOLESTEROL; DIALYSIS FLUID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; MALE; PATIENT MONITORING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 10644265418     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007999909116502     Document Type: Article

References (24)

1. Attman, P. and Alaupovic, P. (1991). Lipid and lipoprotein profiles of uremic dyslipoproteinemia - relation to renal function and dialysis. Nephron, 57, 401-410.
2. Jung, K., Neumann, R., Precht, K. et al. (1980). Lecithin:cholesterol acyltransferase activity, HDL-cholesterol and apolipoprotein A in serum of patients undergoing chronic haemodialysis. Enzyme, 25, 273-275.
3. Jung, K., Scheifler, A., Blank, W. et al. (1988). Changed composition of high density lipoprotein subclasses HDL2 and HDL3 after renal transplantation. Transplant., 46, 407-408.
4. Chan, M. K., Varghese, Z. and Moorhead, J. F. (1981). Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int., 19, 625-637.
5. Jung, K., Scheifler, A., Schulze, B. D. et al. (1995). Lower serum high density lipoprotein cholesterol concentration in patients undergoing maintenance hemodialysis with acetate than with bicarbonate. Am. J. Kidney Dis., 25(4), 584-588.
6. Kaiser, B. A., Assomull, V. M., Vreman, H. J. et al. (1979). Dialysance of acetate and bicarbonate: Effect of ultrafiltration. Proc. Dial. Transplant. Forum, 9, 104-107.
7. Otte, K. E., Lillevang, T., Rasmussen, K. H. et al. (1990). Acetate or bicarbonate for hemodialysis: a randomized, double-blind controlled trial. Nephrol. Dial Transpl., 5, 931-936.
8. Giorcelli, G., Dalmasso, F., Bruno, M. et al. (1979). RDT with acetate-free bicarbonate buffered dialysis fluid: Long term effects on lipid pattern, acid base balance and oxygen delivery. Proc. Eur. Dial. Transpl. Assoc., 16, 115.
9. Docci, D., Capponcini, C., Mengozzi, S. et al. (1995). Effect of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron, 69, 323-326.
10. Lundberg, B., Högström, S., Pietilainen, P. et al. (1984). Separation of plasma high density lipoprotein subclasses by a combined precipitation method using polyethylene glycol 6000 and dextran sulphate. Scand. J. Clin. Lab. Invest., 44, 305-309.
11. Wildhalm, K. and Pakosta, R. (1991). Precipitation with polyethylene glycol and density gradient ultracentrifugation compared for determinig high-density lipoprotein subclasses HDL2 and HDL3. Clin. Chem., 37, 238-240.
12. Friedewald, W. T., Levy, R. I. and Frederickson, D. S. (1976). Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem., 18, 493.
13. Shoji, T., Nishizawa, Y., Nishitani, H. et al. (1992). Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int., 41, 1653-1661.
14. Miller, G. J. and Miller, N. E. (1975). Plasma high density lipoprotein concentration and the development of ischemic heart disease. Lancet, 1, 16.
15. Joven, J., Vilella, E., Ahmad, S. et al. (1993). Lipoprotein heterogeneity in end stage renal disease. Kidney Int., 43, 410-418.
16. Schwartz, C. C., Vlahcevic, Z. R., Berman, M. et al. (1982). Central role of high density lipoprotein in plasma free cholesterol metabolism. J. Clin. Invest., 70, 105-116.
17. Goldberg, I. (1993). Lipoprotein metabolism in normal and uremic patients. Am. J. Kidney Dis., 21(1), 87-90.
18. Glass, C. K., Pittman, R. C., Keller, G. A. et al. (1983). Tissue sites of apoprotein degradation in the rat. J. Biol. Chem., 258, 7161-7167.
19. Dieplinger, H., Schoenfeld, P. Y. and Fielding, C. J. Plasma cholesterol metabolism in end-stage renal disease. J. Clin. Invest., 77, 1071-1083.
20. Kobayashi, N., Okubo, M., Marumo, F. and Nakamura, H. (1983). Effect of dialysis on lipid metabolism in chronic renal failure: Acetate versus bicarbonate. Int. J. Artif. Orgs., 6, 187-190.
21. Akanji, A. O., Bruce, M. A. and Frayn, K. N. (1989). Effect of acetate infusion on energy expenditure and substrate oxidation rates in non-diabetic subjects. Eur. J. Clin. Nutr., 43, 107-115.
22. Wheleer, D. C., Sweny, P., Varghese, Z. and Moorhead, J. F. (1990). Hyperlipidemia and atherosclerosis in chronic renal dialysis patients. Replacement of renal function by dialysis. In Maher, J. (Ed.), A Textbook of Dialysis, Kluwer, Boston, pp. 788-807.
23. Vincenti, P., Amend, W. J., Abele, J. et al. (1980). The role of hypertension in hemodialysis associated atherosclerosis. Am. J. Med., 68, 363-369.
24. Appel, G. (1991). Lipid abnormalities in renal disease. Kidney Int., 39, 169-183.